The effect of 12 weeks of aerobic and resistance exercise on blood pressure

The effect of 12 weeks of aerobic and resistance exercise on hemodynamic, biochemical and functional factors in women with hypertension

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191123045478N1

Enrollment

Registered

2020-12-16

Start date

2020-12-22

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Blood Pressure. Condition 2: Aerobic Exercise. Abnormal blood-pressure reading, without diagnosis Activity, aerobic and step exercise

Interventions

Intervention 1: Control group without exercise or Intervention: Participants in this group will have no exercise during the study. Intervention 2: Intervention group high intensity interval Aerobic tr

Eligibility

Sex/Gender

Female

Age

33 Years to 55 Years

Inclusion criteria

Inclusion criteria: the Patient with high blood pressre (pre to stage 1 hypertension) premenopausal free of any chronic, cardiovascular, metabolic, renal or respiratory disease No physical and functional limitations non-smokers Age between 33 to 55 years

Exclusion criteria

Exclusion criteria: use of any medications that may affect blood pressure and cardiovascular responses regular exercise within the last six months history of myocardial infarction and angioplasty abnormalities of ECG, echo, and stress test

Design outcomes

Primary

Measure	Time frame
Cortisol. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Nitric Oxide. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Endothelin-1. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Total Antioxidant Capacity. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Reactive oxygen species. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Peripheral Vascular Resistance. Timepoint: Before and after intervention. Method of measurement: with Doppler ultrasonography.;Endothelial-dependent vasodilation. Timepoint: Before and after intervention. Method of measurement: with Doppler ultrasonography.	—

Measure

Time frame

Cortisol. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Nitric Oxide. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Endothelin-1. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Total Antioxidant Capacity. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Reactive oxygen species. Timepoint: Before and after intervention. Method of measurement: With ElISA kit.;Peripheral Vascular Resistance. Timepoint: Before and after intervention. Method of measurement: with Doppler ultrasonography.;Endothelial-dependent vasodilation. Timepoint: Before and after intervention. Method of measurement: with Doppler ultrasonography.

—

Secondary

Measure	Time frame
Systolic blood pressure. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.;Diastolic blood pressure. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.;Mean arterial pressure. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.;Heart rate. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.	—

Measure

Time frame

Systolic blood pressure. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.;Diastolic blood pressure. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.;Mean arterial pressure. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.;Heart rate. Timepoint: Before and after intervention. Method of measurement: Digital Aneroid Sphygmomanometer Measure.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Payman Izadpanah

Shiraz University of Medical Sciences

paymanizadpanah@gmail.com+98 71 3739 8811

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026